VivoSeq
Other

Muscle Relaxation

0

Pipeline Programs

1

Active Trials

1

Companies Involved

Muscle Relaxation is an early-stage landscape with 0 programs across 1 company. The most active players are Jiangsu Nhwa Pharmaceutical Co., Ltd..

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

9/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

11

clinical trials

Completed9 · 82%
Recruiting1 · 9%
Terminated1 · 9%

Trial Activity

11 trials

Effect of MgSO4 Pretreatment on Muscle Relaxation
Recruiting··Phase 2/3·NCT05757999·100 enrolled
Muscle Relaxation for Short Procedures
Completed··N/A·NCT01902641·105 enrolled
Paraspinal Muscle Relaxation in Spine Surgery
Completed··N/A·NCT03318718·25 enrolled
The Muscle Relaxation-study
Completed·HHerlev Hospital·Phase 4·NCT01523886·49 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)